1,029 filings
Page 17 of 52
CORRESP
o3n7q8wez6xbcy6tx
6 Sep 19
Correspondence with SEC
12:00am
8-K
0peigkog fwj4c6wvyf
3 Sep 19
Trovagene to Present at the H.C. Wainwright 21st Annual Global Investment Conference
12:33pm
D
wd04b6gxnssn7
28 Aug 19
$1.5M in equity / options / securities to be acquired, sold $1.5M, 1 investor
5:24pm
8-K
e8lx0iy4a
26 Aug 19
Other Events
1:50pm
424B5
b4bkz
21 Aug 19
Prospectus supplement for primary offering
9:42pm
8-K
7k7ei246q4qrj
21 Aug 19
Entry into a Material Definitive Agreement
8:25am
8-K
dydv5mr
15 Aug 19
Other Events
12:00am
8-K
i2rj44t
8 Aug 19
Trovagene Announces Second Quarter 2019 Results and Highlights
4:53pm
8-K
mx6cinn
22 Jul 19
ESMO Accepts Trovagene AML Clinical Trial Abstract for Oral Presentation
11:55am
8-K
gph921b1q7slx z2l7
15 Jul 19
Regulation FD Disclosure
12:03pm
8-K
38x 9in49ltxgf
9 Jul 19
Trovagene Announces Initiation of Enrollment for Phase 1b/2 Clinical Trial in KRAS-Mutated Colorectal Cancer at Leading Comprehensive Cancer Centers
11:20am
4
kb5tp3p1q
3 Jul 19
Trovagene / Mark Erlander ownership change
6:21am
EFFECT
ymo8bp 7e4km
2 Jul 19
Notice of effectiveness
12:15am
CORRESP
6vd9mt3
27 Jun 19
Correspondence with SEC
12:00am
UPLOAD
fyy cuwun5n4ol5
27 Jun 19
Letter from SEC
12:00am
S-8
v808gkk
26 Jun 19
Registration of securities for employees
4:31pm
4
bi2wx
24 Jun 19
Trovagene / THOMAS PHD ADAMS ownership change
4:07pm